Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III st
| Image |  |
|---|---|
| Description | scientific article published on 10 May 2016 |
| Author/s |
author: Ronald van Vollenhoven Gerd-Rüdiger Burmester Michael E Weinblatt Paul Emery |
| Publication date | May 10, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |